Judith Ikezuagu
Family Medicine · Hemet, CANPI 1013399104
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.7% of the total across 123 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.5% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,261 and has fallen 98.6% since, to $18 in 2024.
Across 123 payments — averaging $19.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$348
- Bayer$266
- Amgen$178
- Sanofi-aventis U.S. LLC$171
- Johnson & Johnson$164
- Novartis$151
- plus $1K from 24 others
What the payments were for
- Food & beverage$2,400100%
- Education$70%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 21 | $348 |
| Bayer | 11 | $266 |
| Amgen | 9 | $178 |
| Sanofi-aventis U.S. LLC | 7 | $171 |
| Johnson & Johnson | 11 | $164 |
| Novartis | 8 | $151 |
| GSK | 7 | $133 |
| Teva Pharmaceuticals USA, Inc. | 5 | $108 |
| Novo Nordisk | 5 | $90 |
| E.r. Squibb & Sons, L.L.C. | 4 | $81 |
| Esperion Therapeutics, Inc. | 3 | $72 |
| Astellas Pharma US Inc | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 2 | $66 |
| Merck | 3 | $54 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Ironwood Pharmaceuticals, Inc | 2 | $43 |
| Amarin Pharma, Inc. | 2 | $43 |
| Boehringer Ingelheim | 2 | $39 |
| EUSA Pharma (US) LLC | 1 | $34 |
| Recordati_rare_diseases_inc. | 1 | $34 |
| Lilly USA, LLC | 2 | $33 |
| AstraZeneca | 2 | $26 |
| Abbott | 1 | $24 |
| Pfizer | 1 | $23 |
| Corcept Therapeutics | 1 | $23 |
| Lundbeck LLC | 1 | $21 |
| Biogen | 1 | $19 |
| Sun Pharmaceutical Industries Inc. | 1 | $19 |
| Mylan Specialty L.p. | 1 | $17 |
| Neurocrine Biosciences, Inc. | 1 | $13 |
How this compares
$2,407 in reported general payments places this provider in the 85th percentile of 10,533 family medicine providers in California.
Other family medicine in Hemet
- Sherly SoleimanEncino$1.2M
- Pamela KushnerLos Angeles$1.2M
- Sujata NarayanStanford$1.2M
- Jeffrey UngerChino$906K
- Alexander RivkinLos Angeles$866K
- Scott HowellLos Angeles$793K
- Derrick ButlerLos Angeles$692K
- Sandra CalmanMontara$589K
- Anthony JonesOakland$377K
- Amira AyadBakersfield$360K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.